INGN Stock Recent News
INGN LATEST HEADLINES
Inogen, Inc. (NASDAQ:INGN ) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET Company Participants Ryan Peterson - IR Kevin Smith - President and CEO Mike Bourque - CFO Conference Call Participants Lilia-Celine Lozada - JPMorgan James Beer - William Blair Colin Clark - Stifel Michael Matson - Needham & Company Operator Welcome to Inogen's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 6, 2024.
Inogen (INGN) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.42 per share a year ago.
Investing in small-cap stocks can be a gateway to high returns, mainly when these companies exhibit strong growth fundamentals and strategic market positioning. Here, the focus is on three stocks to buy under $10.
Expanding product portfolio and high prospects for POC raise optimism for Inogen (INGN) stock.
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith joins Inogen from Sirtex Medical, where he served as General Counsel and Executive Vice President, Business Development, since 2018. Mr. Smith brings nearly thirty years of exper.
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces Publication of Study.
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
Inogen, Inc. (NASDAQ:INGN ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and Chief Executive Officer Mike Bourque - Chief Financial Officer Conference Call Participants Colin Clark - Stifel Margaret Kaczor - William Blair Mike Matson - Needham & Company Operator Welcome to Inogen's First Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Expanding product portfolio and high prospects for POC raise optimism for Inogen (INGN) stock.